Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2000, Vol. 5 ›› Issue (2): 138-141.

Previous Articles     Next Articles

Relative bioavalability of hydrochloride eperisone granule in healthy volunteers

GUO Rui-Chen, WANG Ben-Jie, ZHANG Wen-Dong, LI Chao-Wu, LI Zhi-Li1   

  1. Affiliated Hospital of Shandong Medical University, Jinan, 250012; 1Institute 53 of China's Ordnance Industry, Jinan, 250031
  • Received:2000-03-12 Revised:2000-04-10 Online:2000-06-26 Published:2020-12-01

Abstract: Aim Therelative bio avalability of hydrochloride eperisone granule in 10 healthy volunteers was studied.Methods The time-p lasma concentrations of hydrochloride eperisone granule, as test drug, and my onal, as reference drug, weredetermined by GC-MS, with tolperisone senuingas internal standard.The pharmacokinetic parameters of both reference and test drug werecalculated and analyzed with two-one side test and confidential intervaltest.Results Theresults showed that the AUC0-8, AUC0-∞, Cmax, Tpeak, t1/2 (α)and t1/2(β) were(17.9±1.3)ng·h·ml-1 and(18.6±1.6)ng·h·ml-1, (19.1±1.2)ng·h·ml-1 and (20.2±1.6)ng·h·ml-1, (5.2±0.5)ng·ml-1 and (5.4±0.5)ng·ml-1, (1.05±0.18)h and (1.08±0.23)h, (0.78±0.13)h and (0.82±0.14)h, (1.8±0.3)h and (1.8±0.3)h, respectively.Therelative bioavalability of test drug was (105±5)%.Conclusion I t can be concluded that the test and reference arebioequivalented be tween individuals, preparations and periods.

Key words: eperisone hydrochloride, myonal, bioavalability, bioequivalence, GC-MS, tolperisong

CLC Number: